An assessment of sex bias in neurodevelopmental disorders
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neurodevelopmental disorders such as autism and intellectual disability have a sex bias skewed towards boys; however, systematic assessment of this bias is complicated by the presence of significant genetic and phenotypic heterogeneity of these disorders. METHODS: To assess the extent and characteristics of sex bias, we analyzed the frequency of comorbid features, the magnitude of genetic load, and the existence of family history within 32,155 individuals ascertained clinically for autism or intellectual disability/developmental delay (ID/DD), including a subset of 8,373 individuals carrying rare copy-number variants (CNVs). RESULTS: We find that girls were more likely than boys to show comorbid features within both autism (P = 2.9 × 10(-6), OR = 1.34) and ID/DD (P = 7.2 × 10(-4), OR = 1.08) cohorts. The frequency of comorbid features in ID/DD was higher in boys (1q21.1 deletion, 15q11.2q13.1 duplication) or girls (15q13.3 deletion, 16p11.2 deletion) carrying specific CNVs associated with variable expressivity while such differences were the smallest for syndromic CNVs (Smith-Magenis syndrome, DiGeorge syndrome). The extent of the male sex bias also varied according to the specific comorbid feature, being most extreme for autism with psychiatric comorbidities and least extreme for autism comorbid with epilepsy. The sex ratio was also specific to certain CNVs, from an 8:1 male:female ratio observed among autistic individuals carrying the 22q11.2 duplication to 1.3:1 male:female ratio in those carrying the 16p11.2 deletion. Girls carried a higher burden of large CNVs compared to boys for autism or ID/DD, and this difference diminished when severe comorbidities were considered. Affected boys showed a higher frequency of neuropsychiatric family histories such as autism (P = 0.01) or specific learning disability (P = 0.03), while affected girls showed a higher frequency of developmental family histories such as growth abnormalities (P = 0.02). CONCLUSIONS: The sex bias within neurodevelopmental disorders is influenced by the presence of specific comorbidities, specific CNVs, mutational burden, and pre-existing family history of neurodevelopmental phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In relation to structural variants, some neurodevelopmental condition-related copy number variations display phenotypic sex differences; autism is more common in males with 22q11.2 duplication and 16p11.2 deletion syndromes than in females with these syndromes238.”
From Sex and gender in neurodevelopmental conditions (2023) · cites this paper as [238]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Deafness or partial hearing loss was observed in 2.90% (2.40/4.90% in males/females) vs. 0.50% in the general population for the younger age group (0–15 years), and 3.90% (3.20/6.30% in males/females) vs. 0.80% for the older age group (16–24 years). The study concluded that hearing impairment was nine times more prevalent in the autistic individuals compared to the general population.”
From Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“Prevalence of hearing impairment ranged from ~0% (females) in Polyak et al. (31) a study investigating sex bias in ASD comorbidities to 4.90% in Rydzewska et al. (34) (Figure 8 and Supplementary Material 6).”
From Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review (2021) · cites this paper as [34]
In the citing paper
“Prevalence for vision impairment ranged from ~0% (males and females) in Polyak et al. (34) study examining the impact of sex bias on comorbidities in ASD, to 14.9% in Aldinger et al. (51) (Figure 11 and Supplementary Material 6).”
From Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review (2021) · cites this paper as [34]
In the citing paper
“In agreement with this, the ratio of males to females with either ASD or ID shows a male predominance in both 16p11.2 CNVs [57], suggesting that being female is a protective factor when predicting overall ASD severity in either 16p11.2 CNV [58].”
From 16p11.2 Copy Number Variations and Neurodevelopmental Disorders (2020) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745 · cited 1×
“3 deletion [27–29], 22q11.”
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734 · cited 1×
“2 deletion [30–32], and gene disruptive mutations in CHD2 [33–35] and SYNGAP1 [34–37] have all been significantly associated with ID/DD, autism, and schizophrenia phenotypes from independent cohort studies.”
Association between Microdeletion and Microduplication at 16p11.2 and Autism
Weiss, L. A., Shen, Y., Korn, J. M., Arking, D. E., Miller, D. T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M. A. R., Green, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075974 · Cited by 1,666
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446 · cited 1×
“2 deletion [30–32], and gene disruptive mutations in CHD2 [33–35] and SYNGAP1 [34–37] have all been significantly associated with ID/DD, autism, and schizophrenia phenotypes from independent cohort studies.”
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385 · cited 1×
“2 deletion [30–32], and gene disruptive mutations in CHD2 [33–35] and SYNGAP1 [34–37] have all been significantly associated with ID/DD, autism, and schizophrenia phenotypes from independent cohort studies.”
Naarden Braun, K. V., Lopez, M., White, T., et al. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/y3kk-5x30 · Cited by 1,381
Cited by
Genetic Causes and Modifiers of Autism Spectrum Disorder
Rylaarsdam, L., & Guemez-Gamboa, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00385 · Cited by 560
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Kingdom, R., & Wright, C. F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.920390 · Cited by 287
Bougeard, C., Picarel-Blanchot, F., Schmid, R., Campbell, R., & Buitelaar, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.744709 · Cited by 330
“(34) study examining the impact of sex bias on comorbidities in ASD, to 14.”
BackgroundInfluentialSex and gender in neurodevelopmental conditions
Bölte, S., Neufeld, J., Marschik, P. B., Williams, Z. J., Gallagher, L., & Lai, M.-C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00774-6 · Cited by 249
Pizzo, L., Jensen, M., Polyak, A., Rosenfeld, J. A., Mannik, K., Krishnan, A., McCready, E., Pichon, O., Le Caignec, C., Van Dijck, A., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0266-3 · Cited by 193
Self-citation
Metadata
- Authors
- Polyak, A., Rosenfeld, J. A., & Girirajan, S.
- Affiliations
- Pennsylvania State University (US)
- Baylor College of Medicine (US)
- Corresponding author
- Girirajan, Santhosh
- Venue
- Genome Medicine
- Published
- 2015-08-27
- Volume
- 7
- Issue
- 1
- Pages
- 94-94
- ISSN
- 1756-994X (ISSN-L)
- PMC
- PMC4549901
- OpenAlex
- W1950769362
- Cited by
- 129
- References
- 65
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 20 · 2023: 18 · 2022: 11 · 2021: 12 · 2020: 18 · 2019: 13 · 2018: 8 · 2017: 5 · 2016: 5
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Genome Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation (US) (#5-FY14-66)
- Brain and Behavior Research Foundation (US) (22535)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- sex bias, neurodevelopmental disorders, autism spectrum disorder, intellectual disability, developmental delay, copy number variation, comorbidities, psychiatric comorbidity, epilepsy, 1q21.1 deletion, 16p11.2 deletion, 22q11.2 duplication, variable expressivity, family history (medicine), genetic load, sex ratio
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Phenotype, Sex Factors, Comorbidity, Odds Ratio, Young Adult, DNA Copy Number Variations, Neurodevelopmental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An assessment of sex bias in neurodevelopmental disorders. https://app.cochat.ai/papers/10.1186/s13073-015-0216-5
- The paper
- Polyak, A., Rosenfeld, J. A., & Girirajan, S. (2015). An assessment of sex bias in neurodevelopmental disorders. Genome Medicine. https://doi.org/10.1186/s13073-015-0216-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.